Active Ingredient History
Lactobacillus is a genus of gram-positive, aerotolerant anaerobes or microaerophilic, rod-shaped, non-spore-forming bacteria. Until 2020, the genus Lactobacillus comprised over 260 phylogenetically, ecologically, and metabolically diverse species; a taxonomic revision of the genus assigned lactobacilli to 25 genera. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Abdominal Injuries (Phase 2/Phase 3)
Abdominal Pain (Phase 3)
Acute-On-Chronic Liver Failure (Phase 2/Phase 3)
Adenomatous Polyposis Coli (Phase 2)
Ascites (Phase 2)
Asthma (Phase 2/Phase 3)
Basal Ganglia Diseases (Phase 4)
Brain Diseases (Phase 4)
Candidiasis, Vulvovaginal (Phase 4)
Carcinoma, Transitional Cell (Phase 4)
Celiac Disease (Phase 4)
Central Nervous System Diseases (Phase 4)
Clostridium Infections (Phase 3)
Colic (Phase 4)
Colitis, Ulcerative (Phase 1)
Colonic Diseases, Functional (Phase 1/Phase 2)
Communicable Diseases (Phase 2)
Constipation (Phase 3)
Coronavirus Infections (Phase 2)
COVID-19 (Phase 2)
Crohn Disease (Phase 4)
Defecation (Phase 2/Phase 3)
Deglutition Disorders (Early Phase 1)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diarrhea (Phase 3)
Digestive System Diseases (Phase 1/Phase 2)
Drug Resistance, Bacterial (Phase 2)
Dyspepsia (Phase 2/Phase 3)
Fatty Liver (Phase 1)
Helicobacter pylori (Phase 4)
Hepatic Encephalopathy (Phase 3)
Hirschsprung Disease (Phase 2)
Hyperoxaluria (Phase 1/Phase 2)
Hypertension (Early Phase 1)
Inflammatory Bowel Diseases (Phase 3)
Insulin Resistance (Phase 1/Phase 2)
Interleukin-17 (Phase 1/Phase 2)
Intestinal Neoplasms (Phase 2/Phase 3)
Irritable Bowel Syndrome (Phase 4)
Klebsiella pneumoniae (Phase 1/Phase 2)
Live Birth (Phase 2)
Liver Cirrhosis (Phase 2/Phase 3)
Lower Urinary Tract Symptoms (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Menopause (Phase 2)
Metabolic Syndrome (Phase 4)
Movement Disorders (Phase 4)
Mucositis (Phase 3)
Neonatal Sepsis (Phase 3)
Neoplasms (Phase 3)
Nephrolithiasis (Phase 1/Phase 2)
Nervous System Diseases (Phase 4)
Neurodegenerative Diseases (Phase 4)
Non-alcoholic Fatty Liver Disease (Phase 1/Phase 2)
Osteoporosis (Phase 2)
Parkinson Disease (Phase 4)
Parkinsonian Disorders (Phase 4)
Peritonitis (Phase 2/Phase 3)
Pneumonia, Viral (Phase 2)
Polycystic Ovary Syndrome (Phase 3)
Pregnancy (Phase 4)
Probiotics (Phase 4)
Quality of Life (Phase 3)
Recurrence (Phase 4)
Respiratory Tract Infections (Phase 2)
Rhinitis, Allergic (Phase 4)
Rhinitis, Allergic, Seasonal (Phase 3)
Scleroderma, Systemic (Phase 4)
Sjogren's Syndrome (Phase 1/Phase 2)
Stomatitis (Phase 2)
Urinary Tract Infections (Phase 2)
Vaginosis, Bacterial (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
